PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Wuling Motors Holdings Limited (0305.HK)
0.690.03 (-4.17%)
0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.81%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-20.70%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-93.78%
Negative EBIT growth while 0425.HK is at 3.86%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.78%
Negative operating income growth while 0425.HK is at 3.86%. Joel Greenblatt would press for urgent turnaround measures.
-52.25%
Negative net income growth while 0425.HK stands at 1.42%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-41.23%
Negative EPS growth while 0425.HK is at 1.19%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-51.99%
Negative diluted EPS growth while 0425.HK is at 1.19%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-18.65%
Share reduction while 0425.HK is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.28%
Reduced diluted shares while 0425.HK is at 0.05%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-759.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-409.50%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-44.67%
Negative 10Y revenue/share CAGR while 0425.HK stands at 404.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-61.60%
Negative 5Y CAGR while 0425.HK stands at 128.26%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-57.14%
Negative 3Y CAGR while 0425.HK stands at 68.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-248.64%
Negative 10Y OCF/share CAGR while 0425.HK stands at 255.60%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-1024.04%
Negative 5Y OCF/share CAGR while 0425.HK is at 425.69%. Joel Greenblatt would question the firm’s operational model or cost structure.
-303.16%
Negative 3Y OCF/share CAGR while 0425.HK stands at 243.63%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-78.89%
Negative 10Y net income/share CAGR while 0425.HK is at 271.72%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-57.34%
Negative 5Y net income/share CAGR while 0425.HK is 86.06%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-26.08%
Negative 3Y CAGR while 0425.HK is 52.50%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-0.74%
Negative 5Y equity/share growth while 0425.HK is at 68.57%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-19.59%
Negative 3Y equity/share growth while 0425.HK is at 39.42%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
27.51%
Below 50% of 0425.HK's 1178.41%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
81.33%
5Y dividend/share CAGR at 50-75% of 0425.HK's 125.21%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
65.59%
3Y dividend/share CAGR similar to 0425.HK's 69.77%. Walter Schloss finds parallel short-term dividend strategies for both companies.
45.51%
Our AR growth while 0425.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-23.96%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
6.27%
Asset growth at 50-75% of 0425.HK's 11.01%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
22.10%
BV/share growth above 1.5x 0425.HK's 2.19%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
89.98%
Debt growth far above 0425.HK's 63.93%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-34.95%
Our R&D shrinks while 0425.HK invests at 3.33%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.22%
We expand SG&A while 0425.HK cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.